The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Ohio Accuses UnitedHealth’s OptumRx of Drug Overcharges

Ohio Accuses UnitedHealth’s OptumRx of Drug Overcharges

March 23, 2019 • By Nate Raymond

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters)—Ohio’s attorney general on Monday said he had filed a lawsuit against UnitedHealth Group Inc’s OptumRx unit, saying the pharmacy benefit manager had overcharged the state nearly $16 million for prescription drugs.

You Might Also Like
  • Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
  • U.S. Accuses UnitedHealth of Medicare Advantage Fraud
  • Ohio Sues Five Drug Companies Over Opioid Crisis

Ohio Attorney General Dave Yost’s lawsuit followed a probe into the extent pharmacy benefit managers (PBMs) like OptumRx had engaged in pricing practices that resulted in the state overpaying for drugs for people covered by state health programs.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The probe, begun under Gov. Mike DeWine before he left his position of attorney general earlier this year, came amid public concerns about skyrocketing drug prices and the role that PBMs as pharmacy middlemen play in contributing to the costs.

Attorney General Yost accused OptumRx of failing for nearly three years to provide agreed-upon discounts for generic drugs purchased by injured workers submitting claims to the Ohio Bureau of Workers’ Compensation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Our review of PBM practices throughout state government is still ongoing,” Attorney General Yost said in a statement. “These are the first raindrops, but there’s a storm a-comin’.”

The lawsuit, filed on Friday in Franklin County Court of Common Pleas, seeks at least $15 million in compensatory damages and $15 million in punitive damages.

OptumRx did not immediately respond to a request for comment. It has previously said the state’s overcharging claims are “without merit.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

PBMs negotiate drug prices for employers and health plans. They typically demand steep discounts off the drugmakers’ list prices for medicines in exchange for including their products on the PBMs’ preferred formularies, or lists of drugs approved for reimbursement.

In Ohio, the Bureau of Workers’ Compensation and the state’s Medicaid program contract with PBMs to manage drug prescriptions for the agencies’ clients.

Yost, who was elected attorney general in November, previously served as the state’s auditor.

In that role, he released a report in August that found PBMs had charged the state’s Medicaid program an average “spread” of 31 percent for generic drugs, billing $208 million more from April 2017 through March 2018 than it cost to reimburse pharmacies.

OptumRx is the PBM for one of Ohio’s five Medicaid managed-care plans. CVS Health’s CVS Caremark unit acts as the PBM for the other four. The two companies administer $2.5 billion in annual Medicaid drug spending for Ohio.

OptumRx had also contracted with the workers’ compensation agency. But last year, the agency announced it had hired another company to manage its pharmaceutical program for injured workers amid claims OptumRx overcharged it.

Pages: 1 2 | Single Page

Filed Under: Legal, Professional Topics Tagged With: lawsuit, Legal, Ohio, pharmacy benefit managers, pharmacy benefit managers (PBMs)

You Might Also Like:
  • Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
  • U.S. Accuses UnitedHealth of Medicare Advantage Fraud
  • Ohio Sues Five Drug Companies Over Opioid Crisis
  • Kentucky Accuses Endo of Contributing to Opioid Epidemic

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.